Studies using ALK1 transgenic mouse models of HHT discovered that although an increase in PI3K signaling by itself is not sufficient to trigger AVMs, overactivation of PI3K/AKT pathway was involved in HHT2 mice [98]. The gene discussed is PIK3CA; the disease is hereditary hemorrhagic telangiectasia.